The Implications of Fruit and Vegetable Consumption in Patients with Diabetes
PDF

Keywords

Diabetes
flavonoids
pharmacology
nutrition

How to Cite

Lee Meier, M., Greenspan, P., A. Keedy, C., & Misher, A. (2021). The Implications of Fruit and Vegetable Consumption in Patients with Diabetes. Journal of Pharmacy and Nutrition Sciences, 11, 28–32. https://doi.org/10.29169/1927-5951.2021.11.04

Abstract

It is widely accepted that the management of diabetes should include both pharmacologic and lifestyle modifications. However, these recommendations are not readily or consistently incorporated into clinical practice. Current guideline recommendations encourage an emphasis on nutrient-dense foods, which include those foods that tend to be high in flavonoids such as fruits and vegetables. Polyphenolic compounds in fruits and vegetables have been shown to affect the same biological processes as certain classes of pharmacological therapy used in the treatment of diabetes. A better understanding of the benefits of these compounds may help healthcare professionals, including pharmacists, communicate dietary recommendations to patients.

https://doi.org/10.29169/1927-5951.2021.11.04
PDF

References

Lifestyle Management: Standards of Medical Care in Diabetes- 2021. American Diabetes Association. Diabetes Care Jan 2019, 42 (Supplement 1) S1-S2; https://doi.org/10.2337/dc19-Sint01

American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan-2015. Endocrine Practice 2015, 21 (Supplement 1). https://doi.org/10.4158/EP15672.GLSUPPL

Mahoney, Sara & Loprinzi, Paul. (2014). Influence of Flavonoid-Rich Fruit and Vegetable Intake on Diabetic Retinopathy and Diabetes-Related Biomarkers. Journal of Diabetes and its Complications. 28. https://doi.org/10.1016/j.jdiacomp.2014.06.011

Du H, Li L, Bennett D, et al. Fresh fruit consumption in relation to incident diabetes and diabetic vascular complications: A 7-y prospective study of 0.5 million Chinese adults. PLoS Med. 2017;14(4):e1002279. Published 2017 Apr 11. https://doi.org/10.1371/journal.pmed.1002279

Chaudhury A, Duvoor C, Reddy Dendi VS, et al. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management. Front Endocrinol (Lausanne). 2017;8:6. Published 2017 Jan 24. https://doi.org/10.3389/fendo.2017.00006

Ikeda, M., Shimazawa, R. Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes. J Gen Fam Med. 2019; 20(4): 129-138. https://doi.org/10.1002/jgf2.244

Kumar S, Narwal S, Kumar V, Prakash O. α-glucosidase inhibitors from plants: A natural approach to treat diabetes. Pharmacogn Rev. 2011;5(9):19-29. https://doi.org/10.4103/0973-7847.79096

McDougal, DJ., et al. Different polyphenolic component or soft fruits inhibit alpha-amylase and alpha-glucosidase. J Agric Food Chem. 2005; 53(7): 2760-2766. https://doi.org/10.1021/jf0489926

Kalra S. Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology. Diabetes Ther. 2014;5(2):355-66. https://doi.org/10.1007/s13300-014-0089-4

Hardman, TC., Rutherford, P., Dubrey, SW., Wierzbicki, AS., Sodium-glucose co-transporter 2 inhibitors: from apple tree to ‘sweet pee.’ Curr Pharm Des. 2010: 16(34): 3830-3838. https://doi.org/10.2174/138161210794455111

Tian C, Ye X, Zhang R, Long J, Ren W, et al. Green Tea Polyphenols Reduced Fat Deposits in High Fat-Fed Rats. PLOS ONE. 2015; 8(9): 10.

Hurtado de llera A, Martin-hidalgo D, Rodriguez-gil JE, Gil MC, Garcia-marin LJ, Bragado MJ. AMP-activated kinase, AMPK, is involved in the maintenance of plasma membrane organization in boar spermatozoa. Biochim Biophys Acta. 2013;1828(9):2143-51. https://doi.org/10.1016/j.bbamem.2013.05.026

Sharma, C., et al. Advanced glycation end-products (AGEs): an emerging concern for processed food industries. J Food Sci Technol. 2015; 52(12): 7561-7576. https://doi.org/10.1007/s13197-015-1851-y

Tessier FJ. The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathol Biol (Paris) . 2010;58:214–9. https://doi.org/10.1016/j.patbio.2009.09.014

Ansari, Nadeem & Moinuddin, Anis Shaikh & Mir, Abdul Rouf & Habib, Safia & Alam, Khursheed & Ali, Asif & Khan, Rizwan Hasan. (2014). Role of Early Glycation Amadori Products of Lysine-Rich Proteins in the Production of Autoantibodies in Diabetes Type 2 Patients. Cell biochemistry and biophysics. 70. https://doi.org/10.1007/s12013-014-9991-7

Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014;18(1):1-14. https://doi.org/10.4196/kjpp.2014.18.1.1

Banser, A., Naafs, J., et al. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus. Pediatr Diabetes. 2016; 17(6): 426-432. https://doi.org/10.1111/pedi.12311

Stirban A, Gawlowski T, Roden M. Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms. Mol Metab. 2013;3(2):94-108. Published 2013 Dec 7. https://doi.org/10.1016/j.molmet.2013.11.006

Fishman, SL., Sonmez, H., et al. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Mol Med 2018; 59(24). https://doi.org/10.1186/s10020-018-0060-3

Kong, Y., Liu, C., Progress of RAGE molecular imaging in Alzheimer’s Disease. Front Aging Neurosci. 2020; 12(227). https://doi.org/10.3389/fnagi.2020.00227

Asadipooya, K., Mae EU. Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: review of the literature. Journal of the Endocrine Society. 2019; 3(10): 1799-1818. https://doi.org/10.1210/js.2019-00160

Luevano-Contreras, C., Chapman, K. Dietary advanced glycation endproducts and aging. Nutrients. 2010: 2(12): 1247-1265. https://doi.org/10.3390/nu2121247

Sanguineti, R., et al. Advanced glycation end products play adverse proinflammatory activities in osteoporosis. Mediators Inflamm. 2014; 2014: 975872. https://doi.org/10.1155/2014/975872

Zhou, Z., Xiong, WC. RAGE and its ligands in bone metabolism. 2011; 3: 768-776. https://doi.org/10.2741/s185

Uribarri, J., Woodruff, S., et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010; 110(6): 911-916. https://doi.org/10.1016/j.jada.2010.03.018

Gkogkolou P, Böhm M. Advanced glycation end products: Key players in skin aging? Dermatoendocrinol. 2012;4(3):259-70. https://doi.org/10.4161/derm.22028

Chen, JH., Lin, X., et al. Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies. Nutr Metab. 2018; 15:72. https://doi.org/10.1186/s12986-018-0306-7

Gruyter, D. Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy. BioMol Concepts. 2016: 7(5): 293-309. https://doi.org/10.1515/bmc-2016-0021

Perrone, A., et al. Advanced glycation end products (AGE): biochemistry, signaling, analytical methods, and epigenetic effects. Oxid Med Cell Longev. 2020; 2020. https://doi.org/10.1155/2020/3818196

Ashraf, JM., et al. Recent advanced in detection of AGEs: immunochemical, bioanalytical and biochemical approaches. IUBMB Life. 2015: 67(12): 897-913. https://doi.org/10.1002/iub.1450

Suantawee, T., et al. Protein glycation inhibitor activity and antioxidant capacity of clove extract. J Food Sci Tenchnol. 2015; 52(6): 3843-3850.

Rubio-Ruiz, ME., Glycation does not modify bovine serum albumin (BSA)-induced reduction of rat aortic relaxation: The response to glycated and nonglycated BSA is lost in metabolic syndrome. Glycobiology. 2008; 18(7): 517-525. https://doi.org/10.1093/glycob/cwn034

Kinoshita, S., et al. Nω-(Carboxymethyl)arginine is one of the dominant advanced glycation end products in glycated collagens and mouse tissues. Oxidative Medicine and Cellular Longevity. 2019. https://doi.org/10.1155/2019/9073451

Salahuddin P, Rabbani G, Hasan Khan R. The role of advanced glycation end products in various -types of neurodgenerative disease: A therapeutic approach. Cell Mol Biol Lett.2014; 19: 407-437. https://doi.org/10.2478/s11658-014-0205-5

Sadowska-Bartosz, I., et al. Kinetics of glycoxidation of bovine serum albumin by glucose, fructose and ribose and its prevention by food components. Molecules. 2014; 19(11): 18828-18849. https://doi.org/10.3390/molecules191118828

Matsuda, H.; Wang, T.; Managi, H.; Yoshikawa, M. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem., 2003, 11, 5317-5323. https://doi.org/10.1016/j.bmc.2003.09.045

Dorsey PG, Greenspan P. Inhibition of nonenzymatic protein glycation by pomegranate and other fruit juices. J Med Food. 2014;17(4):447-54. https://doi.org/10.1089/jmf.2013.0075

Lim, TK. Punica Granatum. Edible Medicinal and Non-Medicinal Plants. 2012;5: 136-194. https://doi.org/10.1007/978-94-007-4053-2_20

Fournet, M., et al. Glycation damage: a possible hub for major pathophysiological disorders and aging. Aging Dis. 2018; 9(5): 880-900. https://doi.org/10.14336/AD.2017.1121

Mir AR, et al. Methylglyoxal mediated conformational changes in histone H2A-generation of carboxyethylated advanced glycation end products. Int J Biol Macromol, 2014; 69:260-6. https://doi.org/10.1016/j.ijbiomac.2014.05.057

Snedeker, JG., Gautieri, A., The role of collagen crosslinks in aging and diabetes – the good, the bad, and the ugly. Muscles Ligaments Tensons J. 2014: 4(3): 303-308. https://doi.org/10.11138/mltj/2014.4.3.303

Toprak, C., Yigitaslan, S., Alagebrium and complications of diabetes mellitus. Eurasian J Med. 2019; 51(3): 285-292. https://doi.org/10.5152/eurasianjmed.2019.18434

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.